Literature DB >> 19019762

Decreased mortality associated with prompt Gram staining of blood cultures.

Joan Barenfanger1, Donald R Graham, Lavanya Kolluri, Gaurav Sangwan, Jerry Lawhorn, Cheryl A Drake, Steven J Verhulst, Ryan Peterson, Lauren B Moja, Matthew M Ertmoed, Ashley B Moja, Douglas W Shevlin, Robert Vautrain, Charles D Callahan.   

Abstract

Gram stains of positive blood cultures are the most important factor influencing appropriate therapy. The sooner appropriate therapy is initiated, the better. Therefore, it is reasonable to expect that the sooner Gram stains are performed, the better. To determine the value of timely Gram stains and whether improvement in Gram stain turnaround time (TAT) is feasible, we compared data for matched pairs of patients with cultures processed promptly (<1 hour TAT) with data for patients with cultures not processed promptly (> or =1 hour TAT) and then monitored TAT by control charting.In 99 matched pairs, average difference in time to detection of positive blood cultures within a pair of patients was less than 0.1 hour. For the less than 1 hour TAT group, the average TAT and crude mortality were 0.1 hour and 10.1%, respectively; for the 1 hour or longer TAT group, they were 3.3 hours and 19.2%, respectively (P < .0001 and P = .0389, respectively). After multifaceted efforts, we achieved significant improvement in the TAT for Gram stains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019762     DOI: 10.1309/AJCPVMDQU2ZJDPBL

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  39 in total

1.  A comparative evaluation of BACT/ALERT FA PLUS and FN PLUS blood culture bottles and BD BACTEC Plus Aerobic and Anaerobic blood culture bottles for antimicrobial neutralization.

Authors:  Yousun Chung; In-Hee Kim; Minje Han; Hyun Soo Kim; Han-Sung Kim; Wonkeun Song; Jae-Seok Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-02       Impact factor: 3.267

2.  In vitro blood culture bottle inoculation of whole blood with clinically relevant antibiotic concentrations: a word of caution.

Authors:  M Grupper; J L Kuti; D P Nicolau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-28       Impact factor: 3.267

3.  Rapid Direct Susceptibility Testing from Positive Blood Cultures by the Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Direct-on-Target Microdroplet Growth Assay.

Authors:  Evgeny A Idelevich; Luise M Storck; Katrin Sparbier; Oliver Drews; Markus Kostrzewa; Karsten Becker
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

4.  Blood Culture Turnaround Time in U.S. Acute Care Hospitals and Implications for Laboratory Process Optimization.

Authors:  Ying P Tabak; Latha Vankeepuram; Gang Ye; Kay Jeffers; Vikas Gupta; Patrick R Murray
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

5.  Improving timelines in reporting results from positive blood cultures: simulation of impact of rapid identification on therapy on a real-life cohort.

Authors:  Lien Cattoir; Liselotte Coorevits; Isabel Leroux-Roels; Geert Claeys; Bruno Verhasselt; Jerina Boelens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-05       Impact factor: 3.267

6.  Consolidated clinical microbiology laboratories.

Authors:  Robert L Sautter; Richard B Thomson
Journal:  J Clin Microbiol       Date:  2014-09-24       Impact factor: 5.948

7.  Impact of a Rapid Herpes Simplex Virus PCR Assay on Duration of Acyclovir Therapy.

Authors:  Tam T Van; Kanokporn Mongkolrattanothai; Melissa Arevalo; Maryann Lustestica; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2017-03-08       Impact factor: 5.948

8.  The value of outcomes data in the practice of clinical microbiology.

Authors:  Gary V Doern
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

9.  Molecular diagnosis of sepsis: New aspects and recent developments.

Authors:  O Liesenfeld; L Lehman; K-P Hunfeld; G Kost
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

10.  The automated clinical microbiology laboratory: fact or fantasy?

Authors:  Nathan A Ledeboer; Steven D Dallas
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.